Table 3

Means and SDs of outcomes at all time points

OutcomeIntervention group (n=2)Control group (n=2)
Baseline6 weeks12 weeksBaseline6 weeks12 weeks
NEADL29.9±14.432.6±16.435.5±16.930.8±17.031.5±18.532.1±19.0
HADS-A*7.5±5.37.5±4.96.6±5.37.4±5.17.3±4.97.4±4.5
HADS-D*6.9±4.27.1±4.57.1±4.37.1±3.48.2±4.18.1±4.1
SAQOL mean3.4±0.83.3±0.83.4±0.83.2±0.83.2±0.73.1±0.8
SAQOL physical3.4±0.93.3±1.03.4±1.03.1±1.13.1±1.03.0±1.1
SAQOL communication4.0±1.14.0±1.04.2±1.14.1±0.93.9±1.04.0±0.9
SAQOL psychological3.1±1.03.0±1.03.1±1.13.0±1.03.0±0.92.8±0.9
SF-12 physical34.0±8.534.9±10.036.3±10.830.9±10.131.6±7.033.1±8.8
SF-12 mental46.8±12.645.5±11.846.1±10.741.0±14.244.7±13.142.8±11.9
SSEQ25.9±8.625.7±9.426.4±9.023.5±9.721.3±9.221.5±10.6
  • *High scores on HADS indicate worse morbidity, for all other scales this is reversed.

  • HADS-A, Hospital Anxiety and Depression Scale—Anxiety scores; HADS-D, Hospital Anxiety and Depression Scale—Depression scores; NEADL, Nottingham Extended Activities of Daily Living Scale; SAQOL, Stroke and Aphasia Quality of Life scores; SF-12, Short Form 12 questionnaire; SSEQ, Stroke Self-Efficacy Questionnaire.